Malaria antibody protects infants but may weaken vaccine response
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
In a Mali infant study, one dose of the monoclonal antibody L9LS was 78% effective against the malaria parasite over a six-month transmission season. However, it reduced antibody levels generated by the R21 vaccine by 20% to 30%; the effect on real-world vaccine protection remains unclear.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu